240 related articles for article (PubMed ID: 1656076)
1. An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator.
Cohen JI; Kieff E
J Virol; 1991 Nov; 65(11):5880-5. PubMed ID: 1656076
[TBL] [Abstract][Full Text] [Related]
2. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif.
Ling PD; Ryon JJ; Hayward SD
J Virol; 1993 Jun; 67(6):2990-3003. PubMed ID: 8388484
[TBL] [Abstract][Full Text] [Related]
3. The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains.
Tong X; Yalamanchili R; Harada S; Kieff E
J Virol; 1994 Oct; 68(10):6188-97. PubMed ID: 8083959
[TBL] [Abstract][Full Text] [Related]
4. Identification of the Epstein-Barr virus nuclear antigen 2 transactivation domain.
Horvath GC; Schubach WH
Biochem Biophys Res Commun; 1993 Feb; 191(1):196-200. PubMed ID: 8383488
[TBL] [Abstract][Full Text] [Related]
5. Functional domains of Epstein-Barr virus nuclear antigen EBNA-1.
Ambinder RF; Mullen MA; Chang YN; Hayward GS; Hayward SD
J Virol; 1991 Mar; 65(3):1466-78. PubMed ID: 1847464
[TBL] [Abstract][Full Text] [Related]
6. trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.
Reisman D; Sugden B
Mol Cell Biol; 1986 Nov; 6(11):3838-46. PubMed ID: 3025615
[TBL] [Abstract][Full Text] [Related]
7. Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression.
Tsang SF; Wang F; Izumi KM; Kieff E
J Virol; 1991 Dec; 65(12):6765-71. PubMed ID: 1658373
[TBL] [Abstract][Full Text] [Related]
8. oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
Puglielli MT; Woisetschlaeger M; Speck SH
J Virol; 1996 Sep; 70(9):5758-68. PubMed ID: 8709191
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa.
Robertson ES; Grossman S; Johannsen E; Miller C; Lin J; Tomkinson B; Kieff E
J Virol; 1995 May; 69(5):3108-16. PubMed ID: 7707539
[TBL] [Abstract][Full Text] [Related]
10. Interaction of Epstein-Barr virus nuclear antigen 1 with the viral latent origin of replication.
Hearing J; Mülhaupt Y; Harper S
J Virol; 1992 Feb; 66(2):694-705. PubMed ID: 1309908
[TBL] [Abstract][Full Text] [Related]
11. Transcription of the Epstein-Barr virus gene EBNA-1 from different promoters in nasopharyngeal carcinoma and B-lymphoblastoid cells.
Smith PR; Griffin BE
J Virol; 1992 Feb; 66(2):706-14. PubMed ID: 1370554
[TBL] [Abstract][Full Text] [Related]
12. DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines.
Sauder C; Haiss P; Grässer FA; Zimber-Strobl U; Mueller-Lantzsch N
J Gen Virol; 1994 Nov; 75 ( Pt 11)():3067-79. PubMed ID: 7964616
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation.
Harada S; Kieff E
J Virol; 1997 Sep; 71(9):6611-8. PubMed ID: 9261383
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element.
Wang F; Kikutani H; Tsang SF; Kishimoto T; Kieff E
J Virol; 1991 Aug; 65(8):4101-6. PubMed ID: 1649318
[TBL] [Abstract][Full Text] [Related]
15. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
[TBL] [Abstract][Full Text] [Related]
16. A region of herpes simplex virus VP16 can substitute for a transforming domain of Epstein-Barr virus nuclear protein 2.
Cohen JI
Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8030-4. PubMed ID: 1325641
[TBL] [Abstract][Full Text] [Related]
17. The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter.
Le Roux A; Kerdiles B; Walls D; Dedieu JF; Perricaudet M
Virology; 1994 Dec; 205(2):596-602. PubMed ID: 7975264
[TBL] [Abstract][Full Text] [Related]
18. EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus.
Sung NS; Kenney S; Gutsch D; Pagano JS
J Virol; 1991 May; 65(5):2164-9. PubMed ID: 1850003
[TBL] [Abstract][Full Text] [Related]
19. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter.
Zimber-Strobl U; Kremmer E; Grässer F; Marschall G; Laux G; Bornkamm GW
EMBO J; 1993 Jan; 12(1):167-75. PubMed ID: 8381349
[TBL] [Abstract][Full Text] [Related]
20. The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated.
Sample J; Henson EB; Sample C
J Virol; 1992 Aug; 66(8):4654-61. PubMed ID: 1321268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
